Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: a systematic review.

Pego-Reigosa JM, Cobo-Ibáñez T, Calvo-Alén J, Loza-Santamaría E, Rahman A, Muñoz-Fernández S, Rúa-Figueroa Í.

Arthritis Care Res (Hoboken). 2013 Nov;65(11):1775-85. Review.

2.

Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review.

Cobo-Ibáñez T, Loza-Santamaría E, Pego-Reigosa JM, Marqués AO, Rúa-Figueroa I, Fernández-Nebro A, Cáliz Cáliz R, López Longo FJ, Muñoz-Fernández S.

Semin Arthritis Rheum. 2014 Oct;44(2):175-85. doi: 10.1016/j.semarthrit.2014.04.002. Epub 2014 Apr 13. Review.

PMID:
24830791
3.

Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.

Trevisani VF, Castro AA, Neves Neto JF, Atallah AN.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002265. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD002265.

PMID:
16625558
4.

Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus.

Trevisani VF, Castro AA, Neves Neto JF, Atallah AN.

Cochrane Database Syst Rev. 2000;(3):CD002265. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD002265.

PMID:
10908541
5.

Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy.

Sakthiswary R, Suresh E.

Lupus. 2014 Mar;23(3):225-35. doi: 10.1177/0961203313519159. Epub 2014 Jan 7. Review.

PMID:
24399812
6.

Belimumab: review of use in systemic lupus erythematosus.

Boyce EG, Fusco BE.

Clin Ther. 2012 May;34(5):1006-22. doi: 10.1016/j.clinthera.2012.02.028. Epub 2012 Mar 30. Review.

PMID:
22464040
7.

Systemic lupus erythematosus: review of synthetic drugs.

Tsang-A-Sjoe MW, Bultink IE.

Expert Opin Pharmacother. 2015;16(18):2793-806. doi: 10.1517/14656566.2015.1101448. Epub 2015 Oct 19. Review.

PMID:
26479437
8.

Treatment for lupus nephritis.

Flanc RS, Roberts MA, Strippoli GF, Chadban SJ, Kerr PG, Atkins RC.

Cochrane Database Syst Rev. 2004;(1):CD002922. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD002922.

PMID:
14973998
9.

Immunosuppressive drug therapy of systemic lupus erythematosus.

Fox DA, McCune WJ.

Rheum Dis Clin North Am. 1994 Feb;20(1):265-99. Review.

PMID:
8153402
10.

Dehydroepiandrosterone for systemic lupus erythematosus.

Crosbie D, Black C, McIntyre L, Royle PL, Thomas S.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005114. Review.

PMID:
17943841
11.

WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.

Choy EH, Hoogendijk JE, Lecky B, Winer JB, Gordon P.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD003643. doi: 10.1002/14651858.CD003643.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD003643.

PMID:
19821312
12.

Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.

Choy EH, Hoogendijk JE, Lecky B, Winer JB.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003643. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD003643.

PMID:
16034905
13.

Invasive fungal infections in Argentine patients with systemic lupus erythematosus.

Vinicki JP, Catalan Pellet S, Pappalardo C, Cruzat VC, Spinetto MA, Dubinsky D, Tiraboschi IN, Laborde HA, Nasswetter G.

Lupus. 2013 Aug;22(9):892-8. doi: 10.1177/0961203313496342. Epub 2013 Jul 16.

PMID:
23861029
14.

Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.

Pienaar ED, Young T, Holmes H.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003940. doi: 10.1002/14651858.CD003940.pub3. Review.

PMID:
21069679
15.

Therapy of systemic lupus erythematosus: new agents and new evidence.

Ruiz-Irastorza G, Khamashta MA, Hughes GR.

Expert Opin Investig Drugs. 2000 Jul;9(7):1581-93. Review.

PMID:
11060762
16.

Cyclosporin A and therapeutic plasma exchange in the treatment of severe systemic lupus erythematosus.

Bambauer R, Schwarze U, Schiel R.

Artif Organs. 2000 Nov;24(11):852-6.

PMID:
11119071
17.
18.

Belimumab: targeted therapy for lupus.

Chugh PK, Kalra BS.

Int J Rheum Dis. 2013 Feb;16(1):4-13. doi: 10.1111/1756-185x.12002. Epub 2012 Oct 19. Review.

PMID:
23441766
19.

Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.

Aringer M, Graninger WB, Steiner G, Smolen JS.

Arthritis Rheum. 2004 Oct;50(10):3161-9.

20.

Interventions for renal vasculitis in adults. A systematic review.

Walters GD, Willis NS, Craig JC.

BMC Nephrol. 2010 Jun 24;11:12. doi: 10.1186/1471-2369-11-12. Review.

Supplemental Content

Support Center